SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Protocol for an observational study to identify potential predictors of an acute exacerbation in patients with chronic obstructive pulmonary disease (the PACE Study).

Kenn, K; Gloeckl, R; Leitl, D; Schneeberger, T; Jarosch, I; Hitzl, W; Alter, P; Sczepanski, B; Winterkamp, S; Boensch, M; et al. Kenn, K; Gloeckl, R; Leitl, D; Schneeberger, T; Jarosch, I; Hitzl, W; Alter, P; Sczepanski, B; Winterkamp, S; Boensch, M; Schade-Brittinger, C; Skevaki, C; Holz, O; Jones, PW; Vogelmeier, CF; Koczulla, AR (2021) Protocol for an observational study to identify potential predictors of an acute exacerbation in patients with chronic obstructive pulmonary disease (the PACE Study). BMJ Open, 11 (2). ISSN 2044-6055 https://doi.org/10.1136/bmjopen-2020-043014
SGUL Authors: Jones, Paul Wyatt

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (1MB) | Preview

Abstract

INTRODUCTION: Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are the most critical events for patients with COPD that have a negative impact on patients' quality of life, accelerate disease progression, and can result in hospital admissions and death. Although there is no distinct definition or detailed knowledge about AECOPD, it is commonly used as primary outcome in clinical studies. Furthermore, it may be difficult in clinical practice to differentiate the worsening of symptoms due to an AECOPD or to the development of heart failure. Therefore, it is of major clinical importance to investigate the underlying pathophysiology, and if possible, predictors of an AECOPD and thus to identify patients who are at high risk for developing an acute exacerbation. METHODS AND ANALYSIS: In total, 355 patients with COPD will be included prospectively to this study during a 3-week inpatient pulmonary rehabilitation programme at the Schoen Klinik Berchtesgadener Land, Schoenau am Koenigssee (Germany). All patients will be closely monitored from admission to discharge. Lung function, exercise tests, clinical parameters, quality of life, physical activity and symptoms will be recorded, and blood samples and exhaled air will be collected. If a patient develops an AECOPD, there will be additional comprehensive diagnostic assessments to differentiate between cardiac, pulmonary or cardiopulmonary causes of worsening. Follow-up measures will be performed at 6, 12 and 24 months.Exploratory data analyses methods will be used for the primary research question (screening and identification of possible factors to predict an AECOPD). Regression analyses and a generalised linear model with a binomial outcome (AECOPD) will be applied to test if predictors are significant. ETHICS AND DISSEMINATION: This study has been approved by the Ethical Committee of the Philipps University Marburg, Germany (No. 61/19). The results will be presented in conferences and published in a peer-reviewed journal. TRIAL REGISTRATION NUMBER: NCT04140097.

Item Type: Article
Additional Information: Copyright information: © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Keywords: chronic airways disease, emphysema, rehabilitation medicine, thoracic medicine
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: BMJ Open
Article Number: e043014
ISSN: 2044-6055
Language: eng
Dates:
DateEvent
8 February 2021Published
20 January 2021Accepted
Publisher License: Creative Commons: Attribution-Noncommercial 4.0
Projects:
Project IDFunderFunder ID
SFB 1021Deutsche Forschungsgemeinschafthttp://dx.doi.org/10.13039/501100001659
KFO 309Deutsche Forschungsgemeinschafthttp://dx.doi.org/10.13039/501100001659
SK 317/1-1Deutsche Forschungsgemeinschafthttp://dx.doi.org/10.13039/501100001659
PubMed ID: 33558356
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/112992
Publisher's version: https://doi.org/10.1136/bmjopen-2020-043014

Actions (login required)

Edit Item Edit Item